Basic Information
Propagenix's driving mission is to create innovative cell technologies that enable the production and delivery of the next generation of tissue therapies. The company focuses particularly on providing top-tier proprietary cell bioproduction platforms for biopharmaceutical companies engaged in regenerative medicine involving epithelial barrier tissues. Our commitment to this focus is driven by the needs of patients suffering from a variety of conditions, including epithelial barrier dysfunction and tissue damage. Our work is carried out through internal development and strategic partnerships with organizations that share our mission and possess complementary capabilities.
Propagenix Inc
Maryland,United States of America
less than 15 people
April 11, 2011
--

